The authors pooled 40 double-blind placebo-controlled trials covering 1,461 people and 70 exercise measures. Beta-alanine gave a small overall benefit, an effect size of 0.18. The benefit was clearest for exercise capacity tests lasting between 30 seconds and 10 minutes, and was larger when beta-alanine was taken with sodium bicarbonate.
Beta alanine is an amino acid that limits how much carnosine the body can make. Carnosine sits in skeletal muscle and helps control acidity inside the muscle cell during hard effort. An earlier meta analysis had found a benefit for exercise capacity but not for exercise performance, and had put the useful window at 1 to 4 minutes of effort. This team ran a fuller analysis.
This was a systematic review and meta analysis following PRISMA guidelines. Three databases were searched. Only double blind, placebo controlled studies of chronic beta alanine supplementation with an exercise measure were included.
Forty studies met the criteria, using 65 different exercise protocols and producing 70 exercise measures across 1461 participants, 746 on beta alanine and 715 on placebo. One outcome was taken from each protocol and converted to an effect size, a standardized measure of how large a difference is. The authors separate exercise capacity tests, such as time to exhaustion, from performance tests, such as a fixed distance time trial.
The overall effect size was 0.180 (95% CI 0.078 to 0.284), which is small.
Exercise duration was the strongest moderator (p equals 0.004). For efforts of 0.5 to 10 minutes the effect size was 0.224 (95% CI 0.088 to 0.361). For efforts under 0.5 minutes it was 0.040 (95% CI minus 0.220 to 0.300), which is no effect. For over 10 minutes it was 0.174 (95% CI minus 0.030 to 0.377), which did not reach significance.
Several things did not moderate the effect: exercise type overall (p equals 0.256), training status (p equals 0.559), exercise mode (p equals 0.931), continuous against intermittent exercise (p equals 0.436) and total amount ingested (p equals 0.438). Within the 0.5 to 10 minute window, exercise type did matter (p equals 0.01), with capacity tests at 0.4998 (95% CI 0.246 to 0.753) and performance tests at 0.1078 (95% CI minus 0.201 to 0.416), the second of which crosses zero.
Combining beta alanine with sodium bicarbonate gave an effect size of 0.433 against placebo (95% CI 0.230 to 0.637, p less than 0.001) and 0.242 against beta alanine alone (95% CI 0.071 to 0.412, p equals 0.006).
The overall effect is small, and heterogeneity was high, with systematic variance accounting for about 72 percent of total variance, so the average conceals wide variation between studies. The sodium bicarbonate finding rests on six studies only, and the authors say so.
One inconsistency is worth flagging. The meta regression found no significant moderating effect of training status, yet the conclusions state that the effect was clearly demonstrated in non trained individuals with smaller effect sizes in trained populations. The statistical test does not support treating those two groups as different.
Funding came from Brazilian public research agencies, CNPq and FAPESP. Competing interests are declared as none.
This is the strongest available summary of beta alanine research. Efforts lasting roughly half a minute to ten minutes are where the evidence sits. Efforts shorter than that show nothing at all, and the paper is blunt about that.
It does not show a meaningful effect on exercise performance as distinct from exercise capacity. Within the best window, the performance estimate crossed zero. That distinction matters: doing better on a laboratory test to exhaustion is not the same as going faster in a race. The review covers healthy people only, and it cannot say what dose is best, because the total amount ingested did not moderate the result.
That depends on the specific medication and formula. A few, like blood thinners with CurQLife or blood pressure medication with MaxiNOs, are worth a direct conversation with your doctor first. Check each formula's own FAQ section for specifics, or ask your health coach.
No, and we'd rather be upfront about it. Bacopa, the plant in BacoZest, has published human studies, though they used other bacopa extracts. OptiNOs and MaxiNOs each have human studies sponsored by their maker, Laila Nutraceuticals, which haven't been published in a journal. CurQLife's research is still early, from lab and animal studies, and we label it that way.
It depends on what you're building your routine around. BacoZest is built around bacopa, which is studied for memory.* OptiNOs supports strength and muscular endurance alongside resistance training.* MaxiNOs was studied for healthy blood vessel function.* CurQLife's research is still at the lab stage. Your health coach can help you pick a starting point.
All four are built around plant extracts. OptiNOs was reported as well tolerated in its human study, and published bacopa studies reported no serious side effects. CurQLife's safety data so far comes from lab and animal testing. Check with your doctor first if you're pregnant, nursing, on medication, or managing a health condition.
Because the patented ingredients behind our four formulas went through dedicated research, and research costs real money. A generic curcumin or bacopa supplement hasn't been tested in the form you get from us. You're paying for an ingredient with research behind it, not just a label.
Generic ingredients often haven't been studied in the specific form you're buying. Our four core formulas use patented ingredients, and we show you the research behind each one, including where it's still early.
It depends on the formula. In its study, MaxiNOs blood vessel response was higher than placebo 2 to 3 hours after the first dose.* OptiNOs and bacopa were studied over 6 and 12 weeks of daily use, so give them time. CurQLife is meant to be taken daily.
Yes. BacoZest, OptiNOs, MaxiNOs, and CurQLife are built for different goals, and none of them contain stimulants. They haven't been studied together, so ask your health coach how to fit them into your routine.
